CMS recommends additional payment for using Shockwave’s IVL technology in hospital setting

Michael Walter | | Cardiovascular Business | Economics
Intravascular lithotripsy (IVL) therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1. Illustration of the Shockwave lithoplasty procedure using sonic waves to bust calcium without trauma.

CMS has ruled that coronary intravascular lithotripsy (IVL) cases performed in a hospital setting be eligible for an additional payment through a New Technology Add-On Payment (NTAP).

The proposal is included in the Fiscal Year 2022 Hospital Inpatient Prospective Payment System (IPPS) proposed rule, which was published April 27 and is currently open for public comment.

Shockwave Medical, the healthcare technology company that started developing IVL back I 2009, issued a statement in support of the recommendation.

“We applaud CMS for proposing an NTAP for Shockwave’s coronary IVL and for their commitment to improving Medicare beneficiary access to breakthrough technologies,” Robert Fletcher, vice president of marketing and market access for Shockwave Medical, said in a prepared statement. “This is another step forward in our early introduction of coronary IVL and in our mission to expand access to new technology that addresses a significant unmet need in the treatment of complex coronary artery disease.”

Shockwave’s IVL technology has gained FDA approval for the treatment of severely calcified coronary artery disease and peripheral arterial disease.

Click here to read more about IVL in the Cardiology Business digital magazine. More information on the IPPS proposed rule is available here.

 

 

Related Content on Intravascular Lithotripsy to Break Up Calcified Lesions:

VIDEO: Shockwave Medical demonstrates faster intravascular lithotripsy at ACC22

Shockwave’s IVL technology gains FDA approval for treating advanced coronary artery disease

Multicenter trial to evaluate IVL treatment for peripheral lesions below the knee

Better Together? An Integrated Market for Calcium-modification Strategies

IVL Turns Standard Balloon Technology into a Powerful Calcium-disruption Tool

Michael Walter
Michael Walter, Managing Editor

Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Heartflow, a leader in AI-powered imaging evaluations, files for IPO
CMS proposal includes cardiologist pay bump—cuts to high-value services still a concern
AI-enabled coronary plaque evaluations included in new RBM guidelines
Medicare now covers TriClip procedures for patients with symptomatic tricuspid regurgitation
Medical malpractice lawsuits are rare in sports cardiology—but they can cost providers millions
PFA market heats up as medtech companies announce new investments

Around the web

Health Exec
Major association of physicians presents itself as a go-to alternative vs. the government on vaccine expertise

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations. 

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.